BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Biothera Pharmaceuticals Commences Phase II Head and Neck Cancer Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA (pembrolizumab)

  The research deal with Merck will evaluate Biothera’s Imprime PGG in combination with KEYTRUDA.

  February 6, 2018

   · 

  2 min read
• Business

  Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations

  The company will transfer part of its licensed woman’s diagnostic and treatment products to another company including additional territories and provides update on its Alliance joint venture partnership.

  February 6, 2018

   · 

  4 min read
• Drug Development

  Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination With CLAG-M for Relapsed or Refractory AML Patients

  The combination trial will be a Phase 1, dose-escalation study that will be conducted at the Medical College of Wisconsin by principal investigator Dr. Ehab Atallah.

  February 6, 2018

   · 

  7 min read
• Biotech Bay

  PLOS and CSHL Enter Agreement to Enable Preprint Posting on bioRxiv

  PLOS will perform initial manuscript screening, covering scope, plagiarism, and previous publication, and basic ethical and technical criteria.

  February 6, 2018

   · 

  2 min read
• Business

  IRADIMED CORPORATION Announces Fourth Quarter 2017 Financial Results

  For the fourth quarter ended December 31, 2017, the Company reported revenue of $6.7 million compared to $6.0 million for the fourth quarter 2016.

  February 6, 2018

   · 

  16 min read
• Genetown

  Flex Pharma Presenting at BIO CEO on February 13, 2018

  A live webcast of Flex Pharma’s presentations at these conferences may be accessed in the Investor section of the Company’s website at www.flex-pharma.com.

  February 6, 2018

   · 

  1 min read
• Policy

  BioDelivery Sciences Announces BELBUCA Patent Litigation Settlement Agreement With Teva

  The agreement resolves BDSI’s previously reported BELBUCA (buprenorphine) buccal film (CIII), patent litigation against Teva pending in the United States District Court for the District of Delaware.

  February 6, 2018

   · 

  4 min read
• Business

  Wright Medical Group N.V. to Host Fourth Quarter 2017 Earnings Conference Call

  Operating results will be released at 3:00 p.m. Central Time that day.

  February 6, 2018

   · 

  1 min read
• 

  Drug Development

  Celgene’s Multiple Myeloma Triplet Succeeds in Key Phase III Trial

  The international clinical study, OPTIMISMM, achieved its primary endpoint.

  February 6, 2018

   · 

  10 min read
• Business

  Sway Medical Partners With Sport Science Center at TCU to Further Concussion and Sports Performance Research

  Sway is providing a three-year financial commitment to the Sport Science Center with an unrestricted recurring grant to the program.

  February 6, 2018

   · 

  2 min read